Fluticasone furoate, vilanterol 50/25mcg, 100/25mcg, 200/25mcg; per inh; dry pwd for oral inh. Fluticasone furoate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity.

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) is a randomised controlled trial conducted in patients with COPD and comorbid cardiovascular disease, designed to assess the ‘impact of ...

The study was conducted between 2012 and 2015. SLS investigated the effectiveness and safety of initiating treatment with once daily fluticasone furoate/vilanterol 100/25 microgram (FF/VI) compared ...

The announcement comes months after GSK’s struggling respiratory division suffered a setback, when the large-scale SUMMIT trial failed to show its Relvar Ellipta (fluticasone furoate+vilanterol ...

and ensifentrine's top-line exacerbation reduction rate of 40% compares favourably with established therapies like GSK's Breo (fluticasone furoate/vilanterol) and Trelegy (fluticasone furoate ...